Vermillion Renews Partnership With Quest
Vermillion, Inc announces that it has agreed with Quest Diagnostics to extend the Strategic Alliance Agreement between the parties through October, 2009.
Read MoreVermillion, Inc announces that it has agreed with Quest Diagnostics to extend the Strategic Alliance Agreement between the parties through October, 2009.
Read MoreDiaGenic ASA has announced that it has signed a service provider agreement with DNAVision,to offer its innovative blood-based gene-expression diagnostic test for early detection of breast cancer and Alzheimer’s disease.
Read MoreBiosystems International has received venture capital amounting to $4.6 million to foster research and development of lung, colon, and breast cancer diagnostics to be marketed in 2010.
Read MoreOraSure Technologies Inc announces that it has submitted a pre-market approval application to the FDA for its OraQuick HCV test, a rapid test for antibodies to the Hepatitis C virus (HCV).
Read MoreSince bacteria rapidly evolve to evade the action of new antibiotics, the drugs quickly lose their effectiveness. A novel approach to the antibiotic problem, interestingly, is not an antibiotic at all but a new class of anti-microbial agent known as aganocides.
Read More